2021 Vaccines For Adults (VFA)

Award Notice Posted

Not the latest version. See the latest pre-solicitation from .

Solicitation number
75D30121D11353
Agency
Awarded
to Glaxosmithkline, LLC
Set-aside
No set-aside

Opportunity facts

Contract number
75D30121D11353 Federal IDV award
Place of performance
United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Award Notice was published by the Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services on June 25, 2021. It awarded contract 75D30121D11353 to GLAXOSMITHKLINE LLC for the provision of vaccines for adults, with a total award value of $1,560,279,900.00. The contract is to provide vaccines to help protect the adult population from infectious diseases.

Notice text

Awarded contract 75D30121D11353 to GLAXOSMITHKLINE LLC for 156027900.00 on 2021-06-17.

Notice history

Notice Type Posted
Notice of intent to solicit and negotiate a non-competitive modification for PCV 20 vaccine (Prevnar20) Latest Limited / Sole Source Justification
Notice of intent to solicit and negotiate a non-competitive modification for PCV 15 vaccine (VAXNEUVANCE) Limited / Sole Source Justification
Notice of intent to solicit and negotiate a non-competitive modification for PCV 20 vaccine (Prevnar20) Latest pre-solicitation Pre-Solicitation
Notice of intent to solicit and negotiate a non-competitive modification for PCV 15 vaccine (VAXNEUVANCE) Pre-Solicitation
2021 Vaccines For Adults (VFA) Award Notice
2021 Vaccines For Adults (VFA) Award Notice
2021 Vaccines For Adults (VFA) Award Notice
This notice Award Notice
2021 Vaccines For Adults (VFA) Original Solicitation

9 of 11 notices listed here. See the rest on GovTribe.

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors